Georgia Cancer Specialists (GCS) President/CEO Dr. Bruce Feinberg was recently interviewed for two stories that appeared in Forbes Magazine during the month of October. The stories were posted on www.forbes.com, a nationally recognized business news site.
Forbes reporter Kerry Dolan wrote the articles, which focused on physicians’ disapproval of the marketing practices used by the pharmaceutical company Amgen.
“I was happy to be able to contribute my opinions to such a respected publication,” said Dr. Feinberg.
The article stated that Dr. Feinberg and GCS, “one of the five largest cancer practices in the U.S.,” stopped buying the drug Aranesp by Amgen a year ago in response to questionable rebates offered by the company for other Amgen pharmaceuticals.
Dr. Feinberg is often sought out as an expert in all fields of cancer practice, and has been interviewed by national publications several times before, including the New York Times and CNN. He offers comprehensive cancer care at the GCS Stemmer office in Decatur and the GCS Rockdale office in Conyers.